An article titled “Cooling device reduces breast cancer-related alopecia during chemotherapy,” published Dec. 13, 2016, misstated the FDA status of the Orbis Paxman Hair Loss Prevention System. The device has received FDA clearance.
An article titled “Cooling device reduces breast cancer-related alopecia during chemotherapy,” published Dec. 13, 2016, misstated the FDA status of the Orbis Paxman Hair Loss Prevention System. The device has received FDA clearance.
FROM JAMA SURGERY Obese patients who underwent Roux-en-Y gastric bypass had higher percentages of ...
FROM JAMA ONCOLOGY Survival rates overall for cancer patients are higher now than 20 ...
AT THE AMIA 2014 ANNUAL SYMPOSIUM WASHINGTON (FRONTLINE MEDICAL NEWS) – Feeling confused about ...
